You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High dose Methotrexate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation of High Dose Methotrexate Toxicity

Not yet recruiting
  • Methotrexate Toxicity
  • blood methotrexate level and Cystatin C level
  • (no location specified)
Nov 7, 2023

Patients With Cancer Treated With High-dose Methotrexate

Recruiting
  • Acute Kidney Injury
  • Drug Toxicity
  • Marseille, France
  • +4 more
Jun 9, 2023

High-Dose Methotrexate Clearance in Diffuse Large B-Cell

Recruiting
  • Central Nervous System Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Non-Interventional Study
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 8, 2023

Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Paris, France
    Hôpital Pitié-Salpêtrière
Oct 24, 2022

T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

Not yet recruiting
  • T-cell Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
  • Shanghai, Shanghai, China
  • +1 more
Dec 27, 2022

Osteosarcoma Trial in Toronto (High Dose Methotrexate)

Completed
Has Results
  • Osteosarcoma
  • High Dose Methotrexate
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Oct 27, 2021

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Rituximab, Methotrexate, Temozolomide
  • Paris, France
    Groupe Hospitalier Pitie Salpetriere
Feb 10, 2022

Metastatic Breast Cancer, Leptomeningeal Disease Trial in Baltimore, Saint Louis, Winston-Salem (High-dose Methotrexate (8

Recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • High-dose Methotrexate (8 gm/m2; HD-MTX)
  • Baltimore, Maryland
  • +2 more
May 5, 2022

CNS Lymphoma Trial in Berlin (Voraxaze Injectable Product)

Recruiting
  • CNS Lymphoma
  • Voraxaze Injectable Product
  • Berlin, Germany
    Charité Campus Benjamin Franklin (CBF)
Jul 18, 2022

Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

Recruiting
  • Graft-versus-host-disease
  • Relapse
  • Treatment Arm - high dose ATG
  • Control Arm - standard of care
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Oct 14, 2022

Lymphoma, Acute Lymphoblastic Leukemia, Pediatric Cancer Trial in Richmond (Intravenous fluids)

Recruiting
  • Lymphoma
  • +4 more
  • Intravenous fluids
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center/ Children
Aug 25, 2022

CNS Lymphoma Trial in Seongnam-si (lenalidomide)

Recruiting
  • Central Nervous System Lymphoma
  • Seongnam-si, Please Select, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 18, 2022

ALL Trial in Chicago (IOHEXOL)

Completed
  • ALL
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hosptial of Chicago
Jul 26, 2021

Cancer Trial in Houston (Methotrexate)

Completed
Has Results
  • Cancer
  • Houston, Texas
    Texas Children's Hospital
Feb 8, 2021

Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

Completed
Has Results
  • Lymphoblastic Lymphoma
  • San Diego, California
  • +1 more
Jun 7, 2022

CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

Active, not recruiting
  • CNS Lymphoma
  • +2 more
  • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
  • Basking Ridge, New Jersey
  • +2 more
Jan 27, 2023

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • dasatinib plus consolidation chemotherapy with vincristine and prednisone
  • dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021

Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

Recruiting
  • Primary CNS Lymphoma
  • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
  • Moscow, Russian Federation
    Nathional Medical Research Center for Hematology
Jun 16, 2022

Primary CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 30, 2021

Diffuse Large B Cell Lymphoma, CNS Lymphoma Trial in Beijing (Methotrexate)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Central Nervous System Lymphoma
  • Beijing, Beijing, China
    Peking union medical college hospital
Sep 21, 2021

CNS Lymphoma Trial (chidamide combined with rituximab and high-dose methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • chidamide combined with rituximab and high-dose methotrexate
  • (no location specified)
Aug 14, 2020

Primary CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Jul 26, 2022

Mantle Cell Lymphoma Trial in Houston (Bortezomib, Cyclophosphamide, Cytarabine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2022

Osteosarcoma Trial in Worldwide (Calcium Folinate, [6R] 5,10-methylenetetrahydrofolate (arfolitixorin))

Completed
Has Results
  • Osteosarcoma
  • Calcium Folinate
  • [6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
  • Brno, Czechia
  • +4 more
Sep 7, 2020